HDAC6 and amyotrophic lateral sclerosis: HDAC6 inhibitor treatment also increased microtubule-based intracellular transport in motor neurons and fibroblasts derived from patients with amyotrophic lateral sclerosis (ALS) [21, 22] and in Drosophila models of Parkinson’s disease [19] concurrent with improved motor function.